Chuck Ence serves as Executive at RELMADA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Chuck Ence has executed 4 insider transactions totaling $450.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 5, 2025 involved purchasing 136,000 shares valued at $299.2K.
Chuck Ence currently holds 403,931 shares of RELMADA THERAPEUTICS, INC. (RLMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chuck Ence has been a net buyer of RLMD stock. They have purchased $450.1K and sold $0 worth of shares.
Chuck Ence's most recent insider trade was on Nov 5, 2025, when they purchased 136,000 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| $4.05 |
| Discretionary |
| Jan 30, 2024 | RLMD | $56.1K | Purchase | 14,500 | $3.87 | Discretionary |
| Jan 29, 2024 | RLMD | $39.4K | Purchase | 10,800 | $3.65 | Discretionary |